BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S294-S308. [PMID: 9407350 DOI: 10.1111/j.1440-1746.1997.tb00513.x] [Cited by in Crossref: 333] [Cited by in F6Publishing: 305] [Article Influence: 13.9] [Reference Citation Analysis]
Number Citing Articles
1 Chiang CJ, Jhuang JR, Yang YW, Zhuang BZ, You SL, Lee WC, Chen CJ. Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan. JAMA Netw Open 2022;5:e2222367. [PMID: 35849394 DOI: 10.1001/jamanetworkopen.2022.22367] [Reference Citation Analysis]
2 Afifi AM, Elgenidy A, Hashim M, Awad AK, Jalal PK. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Rev Med Virol 2022;:e2353. [PMID: 35441759 DOI: 10.1002/rmv.2353] [Reference Citation Analysis]
3 Costa APDM, da Silva MACN, Castro RS, Sampaio ALDO, Alencar Júnior AM, da Silva MC, Ferreira ADSP. PAGE-B and REACH-B Predicts the Risk of Developing Hepatocellular Carcinoma in Chronic Hepatitis B Patients from Northeast, Brazil. Viruses 2022;14:732. [DOI: 10.3390/v14040732] [Reference Citation Analysis]
4 He Z, Chen J, Wang J, Xu L, Zhou Z, Chen M, Zhang Y, Shi M. Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection. Eur J Gastroenterol Hepatol 2021;33:76-82. [PMID: 32049678 DOI: 10.1097/MEG.0000000000001698] [Reference Citation Analysis]
5 Le AK, Yang HI, Yeh ML, Jin M, Trinh HN, Henry L, Liu A, Zhang JQ, Li J, Wong C, Wong C, Cheung R, Yu ML, Nguyen MH. Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B. J Infect Dis 2021;223:139-46. [PMID: 32525978 DOI: 10.1093/infdis/jiaa330] [Reference Citation Analysis]
6 Ye Z, He Q, Wang Q, Lin Y, Cen K, Chen X. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5. Mol Cell Biochem 2021;476:3757-69. [PMID: 34097192 DOI: 10.1007/s11010-021-04196-0] [Reference Citation Analysis]
7 Suzuki F, Hosaka T, Imaizumi M, Kobayashi M, Ohue C, Suzuki Y, Fujiyama S, Kawamura Y, Sezaki H, Akuta N, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. Hepatology Research 2021;51:426-35. [DOI: 10.1111/hepr.13602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhao H, Song L. TKP, a Serine Protease from Trichosanthes kirilowii, Inhibits Cell Proliferation by Blocking Aerobic Glycolysis in Hepatocellular Carcinoma Cells. Nutr Cancer 2021;:1-13. [PMID: 33544002 DOI: 10.1080/01635581.2021.1882508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mimura S, Fujita K, Takuma K, Nakahara M, Oura K, Tadokoro T, Kobara H, Tani J, Morishita A, Himoto T, Masaki T. Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg. Intern Emerg Med 2021;16:1559-65. [PMID: 33502731 DOI: 10.1007/s11739-020-02622-7] [Reference Citation Analysis]
10 Zhang H, Dong P, Guo S, Tao C, Chen W, Zhao W, Wang J, Cheung R, Villanueva A, Fan J, Ding H, Schrodi SJ, Zhang D, Zeng C. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing. BMC Med 2020;18:200. [PMID: 32741373 DOI: 10.1186/s12916-020-01667-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
11 Xu T, Guo P, Pi C, He Y, Yang H, Hou Y, Feng X, Jiang Q, Wei Y, Zhao L. Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB. J Cancer 2020;11:3955-64. [PMID: 32328199 DOI: 10.7150/jca.41783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Yang J, Qin T, Liu S, Tang H, Liu M, Wang Q. Interaction analysis of miR-1275/IGF2BP1/IGF2BP3 with the susceptibility to hepatocellular carcinoma. Biomark Med 2020;14:283-92. [PMID: 32134323 DOI: 10.2217/bmm-2019-0332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Wang H, Wang B, Wang T, Fan R. A genetic variant in the promoter region of miR-877 is associated with an increased risk of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2020;44:692-8. [PMID: 32113822 DOI: 10.1016/j.clinre.2020.01.006] [Reference Citation Analysis]
14 Zhang C, Cao P, Yang A, Xia X, Li Y, Shi M, Yang Y, Wei X, Yang C, Zhou G. Downregulation of ZC3H14 driven by chromosome 14q31 deletion promotes hepatocellular carcinoma progression by activating integrin signaling. Carcinogenesis 2019;40:474-86. [PMID: 30371740 DOI: 10.1093/carcin/bgy146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Şirin N, Elmas L, Seçme M, Dodurga Y. Investigation of possible effects of apigenin, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells. Gene 2020;737:144428. [PMID: 32045658 DOI: 10.1016/j.gene.2020.144428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Viegas S, Viegas C, Oppliger A. Occupational Exposure to Mycotoxins: Current Knowledge and Prospects. Ann Work Expo Health 2018;62:923-41. [PMID: 30099513 DOI: 10.1093/annweh/wxy070] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
17 Deng Y, Chen ZJ, Lan F, He QT, Chen SY, Du YF, Li S, Qin X. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population. J Clin Lab Anal 2019;33:e22977. [PMID: 31301090 DOI: 10.1002/jcla.22977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Liang W, Zhang Y, Song L, Li Z. 2,3'4,4',5-Pentachlorobiphenyl induces hepatocellular carcinoma cell proliferation through pyruvate kinase M2-dependent glycolysis. Toxicol Lett 2019;313:108-19. [PMID: 31251971 DOI: 10.1016/j.toxlet.2019.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Salum GM, Dawood RM, Abd El-Meguid M, Ibrahim NE, Abdel Aziz AO, El Awady MK. Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients. Genes Dis 2020;7:392-400. [PMID: 32884993 DOI: 10.1016/j.gendis.2019.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Zhu W, Liu H, Zhang X. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection. ACS Infect Dis 2019;5:703-12. [PMID: 30907080 DOI: 10.1021/acsinfecdis.8b00297] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
21 Hosaka T, Suzuki F, Kobayashi M, Fujiyama S, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues. Aliment Pharmacol Ther. 2019;49:457-471. [PMID: 30663078 DOI: 10.1111/apt.15108] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
22 Tchounwou PB, Yedjou CG, Udensi UK, Pacurari M, Stevens JJ, Patlolla AK, Noubissi F, Kumar S. State of the science review of the health effects of inorganic arsenic: Perspectives for future research. Environ Toxicol 2019;34:188-202. [PMID: 30511785 DOI: 10.1002/tox.22673] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
23 Chen YY, Fang WH, Wang CC, Kao TW, Chang YW, Yang HF, Wu CJ, Sun YS, Chen WL. Increased body fat percentage in patients with hepatitis B and C virus infection. PLoS One 2018;13:e0200164. [PMID: 29965999 DOI: 10.1371/journal.pone.0200164] [Reference Citation Analysis]
24 Cao P, Yang A, Wang R, Xia X, Zhai Y, Li Y, Yang F, Cui Y, Xie W, Liu Y, Liu T, Jia W, Jiang Z, Li Z, Han Y, Gao C, Song Q, Xie B, Zhang L, Zhang H, Zhang J, Shen X, Yuan Y, Yu F, Wang Y, Xu J, Ma Y, Mo Z, Yu W, He F, Zhou G. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53. Gastroenterology 2018;155:542-56. [PMID: 29702115 DOI: 10.1053/j.gastro.2018.04.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
25 Wei ZH, Li YY, Huang SQ, Tan ZQ. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population. Cytokine 2019;118:124-9. [PMID: 29656959 DOI: 10.1016/j.cyto.2018.03.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Chen CJ. Global elimination of viral hepatitis and hepatocellular carcinoma: opportunities and challenges. Gut 2018;67:595-8. [PMID: 29367206 DOI: 10.1136/gutjnl-2017-315407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
27 Li F, Qiao CY, Gao S, Fan YC, Chen LY, Wang K. Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy. Free Radic Res 2018;52:455-64. [PMID: 29463155 DOI: 10.1080/10715762.2018.1443448] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kim BS, Seo YS, Kim YS, Lee CH, Lee HA, Um SH, Yoo J, Kim SG, Suh SJ, Jung YK, Ahn SH, Han K, Yim HJ, Kim SU; The Korean Transient Elastography Study Group. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis: Subcirrhotic liver stiffness in HBV. Journal of Gastroenterology and Hepatology 2018;33:503-10. [DOI: 10.1111/jgh.13854] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
29 Shinkai N, Nojima M, Iio E, Matsunami K, Toyoda H, Murakami S, Inoue T, Ogawa S, Kumada T, Tanaka Y. High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues. J Gastroenterol 2018;53:883-9. [PMID: 29288305 DOI: 10.1007/s00535-017-1424-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
30 Huang JL, Fu YP, Jing CY, Yi Y, Sun J, Gan W, Lu ZF, Zhou J, Fan J, Qiu SJ. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection. J Surg Oncol 2018;117:625-33. [PMID: 29165812 DOI: 10.1002/jso.24895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Xiang X, Qin HG, You XM, Wang YY, Qi LN, Ma L, Xiang BD, Zhong JH, Li LQ. Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure. Cancer Med 2017;6:2357-69. [PMID: 28941211 DOI: 10.1002/cam4.1176] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
32 Xie X, Zhou Y, Wang X, Guo J, Li J, Fan H, Dou J, Shen B, Zhou C. Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivo. Carbohydr Polym 2017;173:360-71. [PMID: 28732877 DOI: 10.1016/j.carbpol.2017.06.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
33 Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, Gao Q, Wang XY, Song K, Fan J, Ding ZB. Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma. Infect Agent Cancer 2017;12:28. [PMID: 28559922 DOI: 10.1186/s13027-017-0137-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
34 Chien J, Liu J, Lee MH, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, You SL, Yang HI, Chen CJ. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis. J Gastroenterol Hepatol 2016;31:1971-7. [PMID: 27118149 DOI: 10.1111/jgh.13422] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
35 Sepehri Z, Kiani Z, Kohan F, Alavian SM, Ghavami S. Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sci 2017;179:80-7. [PMID: 28472619 DOI: 10.1016/j.lfs.2017.04.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
36 Su M, Guo J, Huang J. Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma. Clin Mol Hepatol 2017;23:138-46. [PMID: 28427253 DOI: 10.3350/cmh.2016.0083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
37 Lee HL, Cheng HL, Liu YF, Chou MC, Yang SF, Chou YE. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk. PLoS One 2017;12:e0176141. [PMID: 28426730 DOI: 10.1371/journal.pone.0176141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
38 Song L, Guo L, Li Z. Molecular mechanisms of 3,3'4,4',5-pentachlorobiphenyl-induced epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Toxicol Appl Pharmacol 2017;322:75-88. [PMID: 28284859 DOI: 10.1016/j.taap.2017.03.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
39 Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Tanaka J. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic: HCC development in CHB during NA therapy. Journal of Gastroenterology and Hepatology 2017;32:451-8. [DOI: 10.1111/jgh.13473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
40 Hoang JK, Yang HI, Le A, Nguyen NH, Lin D, Vu VD, Chaung K, Nguyen V, Trinh HN, Li J, Zhang JQ, Chen CJ, Nguyen MH. Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine (Baltimore) 2016;95:e4433. [PMID: 27495067 DOI: 10.1097/MD.0000000000004433] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
41 Khezri A, Fallah E, Mostafazadeh M, Spotin A, Shahbazi A, Mahami-Oskouei M, Hazratian T. Molecular and Morphometric Characterization of Acanthamoeba spp. from Different Water Sources of Northwest Iran as a Neglected Focus, Co-Bordered With the Country of Iraq. Jundishapur J Microbiol 2016;9:e38481. [PMID: 28138374 DOI: 10.5812/jjm.38481] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
42 Kim EJ, Yeon JE, Kwon OS, Lee HN, Shin SK, Kang SH, Byun KS, Kim JH, Kwon SY, Suh SJ, Yim HJ, Kim YS, Kim JH. Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis. Dig Dis Sci 2017;62:808-16. [DOI: 10.1007/s10620-016-4431-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
43 Ledda C, Loreto C, Zammit C, Marconi A, Fago L, Matera S, Costanzo V, Fuccio Sanzà G, Palmucci S, Ferrante M, Costa C, Fenga C, Biondi A, Pomara C, Rapisarda V. Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review). Mol Med Rep 2017;15:511-33. [PMID: 28000892 DOI: 10.3892/mmr.2016.6046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
44 Lee HW, Ahn SH. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients. World J Gastroenterol 2016; 22(37): 8314-8321 [PMID: 27729738 DOI: 10.3748/wjg.v22.i37.8314] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
45 Li N, Jiang J, Fu J, Yu T, Wang B, Qin W, Xu A, Wu M, Chen Y, Wang H. Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma. J Exp Clin Cancer Res 2016;35. [DOI: 10.1186/s13046-016-0413-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Chang IC, Huang SF, Chen PJ, Chen CL, Chen CL, Wu CC, Tsai CC, Lee PH, Chen MF, Lee CM, Yu HC, Lo GH, Yeh CT, Hong CC, Eng HL, Wang J, Tseng HH, Hsiao CH, Wu HI, Yen TC, Liaw YF. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network. Medicine (Baltimore) 2016;95:e3284. [PMID: 27082566 DOI: 10.1097/MD.0000000000003284] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
47 Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Ishii A, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study. J Viral Hepat. 2016;23:977-984. [PMID: 27476460 DOI: 10.1111/jvh.12575] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
48 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T, Tanaka J. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics. Journal of Hepatology 2016;65:48-56. [DOI: 10.1016/j.jhep.2016.03.013] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 12.5] [Reference Citation Analysis]
49 Ma X, Yang Y, Tu H, Gao J, Tan YT, Zheng JL, Bray F, Xiang YB. Risk prediction models for hepatocellular carcinoma in different populations. Chin J Cancer Res. 2016;28:150-160. [PMID: 27199512 DOI: 10.21147/j.issn.1000-9604.2016.02.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Ishii A, Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B. Hepatol Res 2017;47:204-15. [PMID: 26990490 DOI: 10.1111/hepr.12703] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
51 Li J, Hou Y, Cai XB, Liu B. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma. World J Gastroenterol 2016; 22(15): 4034-4040 [PMID: 27099447 DOI: 10.3748/wjg.v22.i15.4034] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
52 Wang B, Yeh CB, Lein MY, Su CM, Yang SF, Liu YF, Tang CH. Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma. Int J Med Sci. 2016;13:304-309. [PMID: 27076788 DOI: 10.7150/ijms.14877] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
53 Huang L, Mo Z, Lao X, Zhang X, Liu Y, Sui J, Qin X, Li S. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population. Tumour Biol 2016;37:6599-606. [PMID: 26643892 DOI: 10.1007/s13277-015-4539-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
54 Shen W, Guan Y, Wang J, Hu Y, Tan Q, Song X, Jin Y, Liu Y, Zhang Y. A polysaccharide from pumpkin induces apoptosis of HepG2 cells by activation of mitochondrial pathway. Tumour Biol 2016;37:5239-45. [PMID: 26555544 DOI: 10.1007/s13277-015-4338-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
55 Visvanathan K, Lang T, Ryan K, Wilson R, Skinner NA, Thompson AJ, Ahn SH, Weilert F, Abbott W, Gane E, Colledge D, Li K, Locarnini S, Mansell A, Revill PA. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients. J Viral Hepat 2016;23:170-9. [PMID: 26436722 DOI: 10.1111/jvh.12477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
56 Hung CH, Hu TH, Lu SN, Kuo FY, Chen CH, Wang JH, Huang CM, Lee CM, Lin CY, Yen YH, Chiu YC. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. Int J Cancer. 2016;138:714-720. [PMID: 26264553 DOI: 10.1002/ijc.29802] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
57 Watanabe T, Tokumoto Y, Joko K, Michitaka K, Mashiba T, Hiraoka A, Ochi H, Koizumi Y, Tada F, Hirooka M, Yoshida O, Imai Y, Abe M, Hiasa Y. Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients. Hepatol Int. 2016;10:320-327. [PMID: 26198757 DOI: 10.1007/s12072-015-9647-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
58 Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(27): 8249-8255 [PMID: 26217076 DOI: 10.3748/wjg.v21.i27.8249] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
59 Bastani R, Glenn BA, Maxwell AE, Jo AM, Herrmann AK, Crespi CM, Wong WK, Chang LC, Stewart SL, Nguyen TT, Chen MS Jr, Taylor VM. Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles. Cancer Epidemiol Biomarkers Prev 2015;24:1341-9. [PMID: 26104909 DOI: 10.1158/1055-9965.EPI-14-1396] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
60 Liu Y, Xie L, Zhao J, Huang X, Song L, Luo J, Ma L, Li S, Qin X. Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study. Medicine (Baltimore) 2015;94:e702. [PMID: 25837767 DOI: 10.1097/MD.0000000000000702] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
61 Kim MN, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Song KJ, Park YN, Han KH. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Hepatology 2015;61:1851-9. [PMID: 25643638 DOI: 10.1002/hep.27735] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 14.6] [Reference Citation Analysis]
62 Qu K, Liu SS, Wang ZX, Huang ZC, Liu SN, Chang HL, Xu XS, Lin T, Dong YF, Liu C. Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(14): 4310-4322 [PMID: 25892883 DOI: 10.3748/wjg.v21.i14.4310] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
63 Sheu MJ, Hsieh MJ, Chiang WL, Yang SF, Lee HL, Lee LM, Yeh CB. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. PLoS One 2015;10:e0122961. [PMID: 25860955 DOI: 10.1371/journal.pone.0122961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
64 Wang S, Sugamori KS, Tung A, McPherson JP, Grant DM. N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer. Toxicol Sci 2015;144:393-405. [PMID: 25601990 DOI: 10.1093/toxsci/kfv006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
65 Liu Y, Huang L, Lu Y, Xi XE, Huang XL, Lu Q, Huang X, Li S, Qin X. Relationships between the Osteocalcin gene polymorphisms, serum osteocalcin levels, and hepatitis B virus-related hepatocellular carcinoma in a Chinese population. PLoS One 2015;10:e0116479. [PMID: 25587715 DOI: 10.1371/journal.pone.0116479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
66 Chen CJ, Lee MH, Liu J, Yang HI. Hepatocellular carcinoma risk scores: ready to use in 2015? Hepat Oncol 2015;2:1-4. [PMID: 30190979 DOI: 10.2217/hep.14.32] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
67 Wang JP, Kao F, Wu C, Hung Y, Chao Y, Chou Y, Li C. Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: A population-based cohort study: NAs Reduce Risk of HCC in Chronic Hepatitis B. Cancer 2015;121:1446-55. [DOI: 10.1002/cncr.29159] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
68 Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, Wang LY, You SL, Hsiao CK, Chen PJ, Chen CJ; R.E.V.E.A.L.-HBV Study Group. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Gut 2014;63:1648-57. [PMID: 24225939 DOI: 10.1136/gutjnl-2013-305785] [Cited by in Crossref: 122] [Cited by in F6Publishing: 100] [Article Influence: 15.3] [Reference Citation Analysis]
69 Daoudaki M, Fouzas I. Hepatocellular carcinoma. Wien Med Wochenschr 2014;164:450-5. [PMID: 25182146 DOI: 10.1007/s10354-014-0296-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
70 Chen TP, Yang SF, Lin CW, Lee HL, Tsai CM, Weng CJ. A4383C and C76G SNP in Cathepsin B is respectively associated with the high risk and tumor size of hepatocarcinoma. Tumour Biol 2014;35:11193-8. [PMID: 25106406 DOI: 10.1007/s13277-014-2004-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
71 Liu Y, Liu Y, Huang X, Sui J, Mo C, Wang J, Peng Q, Deng Y, Huang L, Li S, Qin X. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population. Infect Genet Evol 2014;27:69-76. [PMID: 25014269 DOI: 10.1016/j.meegid.2014.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
72 Yang HI, Lee MH, Liu J, Chen CJ. Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia. World J Gastroenterol 2014; 20(20): 6244-6251 [PMID: 24876745 DOI: 10.3748/wjg.v20.i20.6244] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
73 Rashad NM, El-Shal AS, Abd Elbary EH, Abo Warda MH, Hegazy O. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 2014;68:50-8. [PMID: 24656929 DOI: 10.1016/j.cyto.2014.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
74 Hsieh MC, Hsu HT, Hsiao PC, Yang SF, Yeh CB, Bien MY, Lin CH, Chien MH. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. J Clin Lab Anal 2014;28:237-44. [PMID: 24478168 DOI: 10.1002/jcla.21672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
75 Chen H, Miao J, Li H, Wang C, Li J, Zhu Y, Wang J, Wu X, Qiao H. Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma. J Surg Res. 2014;189:81-88. [PMID: 24576777 DOI: 10.1016/j.jss.2014.01.049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
76 Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De Xiang B, Peng T, Han ZG, Li LQ. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China: role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Liver Int. 2015;35:999-1009. [PMID: 24461059 DOI: 10.1111/liv.12460] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
77 Hsiao PJ, Jao JC, Tsai JL, Chang WT, Jeng KS, Kuo KK. Inorganic arsenic trioxide induces gap junction loss in association with the downregulation of connexin43 and E-cadherin in rat hepatic "stem-like" cells. Kaohsiung J Med Sci 2014;30:57-67. [PMID: 24444534 DOI: 10.1016/j.kjms.2013.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kim CJ, Shin JW, Jung SW, Park BR, Cha HJ, Park NH. Mutational analysis of FEN1 gene in hepatocellular carcinomas. APMIS 2014;122:663-5. [PMID: 24164220 DOI: 10.1111/apm.12202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
79 Lu JW, Yang WY, Tsai SM, Lin YM, Chang PH, Chen JR, Wang HD, Wu JL, Jin SL, Yuh CH. Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish. PLoS One. 2013;8:e76951. [PMID: 24130815 DOI: 10.1371/journal.pone.0076951] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
80 Yu YL, Su KJ, Hsieh YH, Lee HL, Chen TY, Hsiao PC, Yang SF. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma. PLoS One 2013;8:e74870. [PMID: 24040354 DOI: 10.1371/journal.pone.0074870] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
81 Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation. J Clin Gastroenterol. 2013;47:359-366. [PMID: 23090049 DOI: 10.1097/mcg.0b013e31826be9ad] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
82 Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 2013;58:98-107. [PMID: 23213040 DOI: 10.1002/hep.26180] [Cited by in Crossref: 490] [Cited by in F6Publishing: 435] [Article Influence: 54.4] [Reference Citation Analysis]
83 Yu Q, Zhou C, Wang J, Chen L, Zheng S, Zhang J. A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population. DNA Cell Biol 2013;32:451-7. [PMID: 23777424 DOI: 10.1089/dna.2013.2061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
84 Steinberg C, Boudreau S, Leveille F, Lamothe M, Chagnon P, Boulais I. Advanced hepatocellular carcinoma with subtotal occlusion of the inferior vena cava and a right atrial mass. Case Rep Vasc Med 2013;2013:489373. [PMID: 23662245 DOI: 10.1155/2013/489373] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
85 Shyu HJ, Lung CC, Ho CC, Sun YH, Ko PC, Huang JY, Pan CC, Chiang YC, Chen SC, Liaw YP. Geographic patterns of hepatocellular carcinoma mortality with exposure to iron in groundwater in Taiwanese population: an ecological study. BMC Public Health 2013;13:352. [PMID: 23590585 DOI: 10.1186/1471-2458-13-352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
86 Lin C, Lin C, Mo L, Chang C, Perng D, Hsu C, Lo G, Chen Y, Yen Y, Hu J, Yu M, Lee P, Lin J, Yang S. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. Journal of Hepatology 2013;58:730-5. [DOI: 10.1016/j.jhep.2012.11.045] [Cited by in Crossref: 86] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
87 Bose S, Tripathi DM, Sukriti, Sakhuja P, Kazim SN, Sarin SK. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene 2013;519:231-7. [PMID: 23454624 DOI: 10.1016/j.gene.2013.02.025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
88 Hamid AS, Tesfamariam IG, Zhang Y, Zhang ZG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncol Lett 2013;5:1087-92. [PMID: 23599745 DOI: 10.3892/ol.2013.1169] [Cited by in Crossref: 149] [Cited by in F6Publishing: 123] [Article Influence: 16.6] [Reference Citation Analysis]
89 Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O, Hassan M. Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World J Hepatol 2012; 4(12): 342-355 [PMID: 23355912 DOI: 10.4254/wjh.v4.i12.342] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
90 Uccello M, Malaguarnera G, Corriere T, Biondi A, Basile F, Malaguarnera M. Risk of hepatocellular carcinoma in workers exposed to chemicals. Hepat Mon. 2012;12:e5943. [PMID: 23162599 DOI: 10.5812/hepatmon.5943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
91 Zhang YJ, Wu HC, Yazici H, Yu MW, Lee PH, Santella RM. Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure. World J Hepatol 2012;4:169-75. [PMID: 22666524 DOI: 10.4254/wjh.v4.i5.169.] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
92 Abdalla MA, Haj-Ahmad Y. Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J Cancer. 2012;3:390-403. [PMID: 23074380 DOI: 10.7150/jca.4280] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
93 Zhu X, Qin X, Fei M, Hou W, Greshock J, Bachman KE, Wooster R, Kang J, Qin CY. Combined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinoma. Int J Mol Sci. 2012;13:9980-9991. [PMID: 22949843 DOI: 10.3390/ijms13089980] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
94 Fan S, Eiser C, Ho M, Lin C. Health-related quality of life in patients with hepatocellular carcinoma: the mediation effects of illness perceptions and coping: HRQOL in patients with HCC. Psycho-Oncology 2013;22:1353-60. [DOI: 10.1002/pon.3146] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
95 Cui BK, Liu S, Li SH, Wang J, Wang QB, Li SP, Lin XJ. Effect of tea polyphenol on oxidative injury in S180 cells induced hepatocarcinoma mice. Int J Mol Sci 2012;13:5571-83. [PMID: 22754316 DOI: 10.3390/ijms13055571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Zhang YJ, Wu HC, Yazici H, Yu MW, Lee PH, Santella RM. Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B1 exposure. World J Hepatol 2012; 4(5): 169-175 [DOI: 10.4254/wjh.v4.i5.169] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
97 Morace C, Cucunato M, Bellerone R, De Caro G, Crinò S, Fortiguerra A, Spadaro F, Zirilli A, Alibrandi A, Consolo P, Luigiano C, Resta ML, Ferraù O, Spadaro A. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? Eur J Intern Med 2012;23:e157-61. [PMID: 22863442 DOI: 10.1016/j.ejim.2012.04.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
98 Liao SF, Yang HI, Lee MH, Chen CJ, Lee WC. Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan. PLoS One. 2012;7:e34779. [PMID: 22506050 DOI: 10.1371/journal.pone.0034779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
99 Li S, Huang Z, Hsieh H, Yu W, Tzeng W, Lee G, Chen Y, Chang C, Chuu J. The Augmented Anti-Tumor Effects of Antrodia camphorata Co-Fermented with Chinese Medicinal Herb in Human Hepatoma Cells. Am J Chin Med 2012;37:771-83. [DOI: 10.1142/s0192415x09007235] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
100 Shitani M, Sasaki S, Akutsu N, Takagi H, Suzuki H, Nojima M, Yamamoto H, Tokino T, Hirata K, Imai K. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Tumour Biol. 2012;33:1307-1317. [PMID: 22457049 DOI: 10.1007/s13277-012-0378-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
101 Walter SR, Thein HH, Gidding HF, Amin J, Law MG, George J, Dore GJ. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. J Gastroenterol Hepatol 2011;26:1757-64. [PMID: 21615789 DOI: 10.1111/j.1440-1746.2011.06785.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
102 Zhang J, Xu F, Ouyang C. Joint effect of polymorphism in the N-acetyltransferase 2 gene and smoking on hepatocellular carcinoma. Tumour Biol. 2012;33:1059-1063. [PMID: 22293947 DOI: 10.1007/s13277-012-0340-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
103 Fan S, Eiser C. Illness experience in patients with hepatocellular carcinoma: an interpretative phenomenological analysis study. European Journal of Gastroenterology & Hepatology 2012;24:203-8. [DOI: 10.1097/meg.0b013e32834ec184] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
104 Jin Y, Yu Q, Zhou D, Chen L, Huang X, Xu G, Huang J, Gao X, Gao Y, Shen L. The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population. Genet Test Mol Biomarkers 2012;16:330-4. [PMID: 22283196 DOI: 10.1089/gtmb.2011.0208] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
105 Kurokawa M, Hiramatsu N, Oze T, Yakushijin T, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Ishida H, Tatsumi T, Kiso S, Kanto T, Kasahara A, Iio S, Doi Y, Yamada A, Oshita M, Kaneko A, Mochizuki K, Hagiwara H, Mita E, Ito T, Inui Y, Katayama K, Yoshihara H, Imai Y, Hayashi E, Hayashi N, Takehara T. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection. J Gastroenterol 2012;47:577-85. [PMID: 22231575 DOI: 10.1007/s00535-011-0522-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
106 Wei S, Xiong M, Zhan DQ, Liang BY, Wang YY, Gutmann DH, Huang ZY, Chen XP. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway. Carcinogenesis 2012;33:538-47. [PMID: 22226916 DOI: 10.1093/carcin/bgr319] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
107 Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011;29:4781-8. [PMID: 22105822 DOI: 10.1200/JCO.2011.38.2697] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
108 Hsieh YS, Tsai CM, Yeh CB, Yang SF, Hsieh YH, Weng CJ. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma. Ann Surg Oncol. 2012;19 Suppl 3:S625-S633. [PMID: 22052111 DOI: 10.1245/s10434-011-2123-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
109 Lu T, Huang Y, Chiang T. Using the diamond model to prioritize 30 causes of death by considering both the level of and inequality in mortality. Health Policy 2011;103:63-72. [DOI: 10.1016/j.healthpol.2011.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
110 Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011;21:401-416. [PMID: 22041528 DOI: 10.2188/jea.je20100190.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011;21:401-416. [PMID: 22041528 DOI: 10.2188/jea.je20100190] [Cited by in Crossref: 183] [Cited by in F6Publishing: 128] [Article Influence: 16.6] [Reference Citation Analysis]
112 Chen C, Lee W, Yang H, Chang H, Jen C, Iloeje UH, Su J, Hsiao CK, Wang L, You S, Lu S, Chen C. Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma. Gastroenterology 2011;141:1240-1248.e2. [DOI: 10.1053/j.gastro.2011.06.036] [Cited by in Crossref: 152] [Cited by in F6Publishing: 142] [Article Influence: 13.8] [Reference Citation Analysis]
113 Fielding L. Current imaging strategies of primary and secondary neoplasms of the liver. Semin Intervent Radiol 2006;23:3-12. [PMID: 21326715 DOI: 10.1055/s-2006-939836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
114 Song M, Kim Y, Song M, Choi H, Park Y, Ryu J. Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction. Cancer Science 2011;102:1636-44. [DOI: 10.1111/j.1349-7006.2011.02000.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
115 Lu J, Hsia Y, Tu H, Hsiao Y, Yang W, Wang H, Yuh C. Liver development and cancer formation in zebrafish. Birth Defects Research Part C: Embryo Today: Reviews 2011;93:157-72. [DOI: 10.1002/bdrc.20205] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
116 Jiang X, Zou Y, Huo Z, Yu P. Association of major histocompatibility complex class I chain-related gene A microsatellite polymorphism and hepatocellular carcinoma in South China Han population. Tissue Antigens 2011;78:143-7. [DOI: 10.1111/j.1399-0039.2011.01693.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
117 Chang CY, Cheng TJ, Chang FR, Wang HY, Kan WC, Li SL, Huang LH, Chen YC, Tsai WC, Huang CH, Cheng CH, Lee GY, Shyue SW, Chen YP, Lin KC, Chuu JJ. Macrophage mediated anti-proliferation effects of Anthodia camphorata non-polysaccharide based extracts on human hepatoma cells. Biosci Biotechnol Biochem 2011;75:624-32. [PMID: 21512226 DOI: 10.1271/bbb.100559] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
118 Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK;  REACH-B Working Group. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011;12:568-574. [PMID: 21497551 DOI: 10.1016/s1470-2045(11)70077-8] [Cited by in Crossref: 366] [Cited by in F6Publishing: 146] [Article Influence: 33.3] [Reference Citation Analysis]
119 Vezali E, Aghemo A, Lampertico P, Colombo M. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis? Clin Res Hepatol Gastroenterol 2011;35:455-64. [PMID: 21435968 DOI: 10.1016/j.clinre.2011.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
120 Chen TY, Li YC, Liu YF, Tsai CM, Hsieh YH, Lin CW, Yang SF, Weng CJ. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma. Ann Surg Oncol 2011;18:2348-56. [PMID: 21298348 DOI: 10.1245/s10434-011-1574-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
121 Wu C, Chan T, Changchien C, Yang C. Parity, age at first birth, and risk of death from liver cancer: Evidence from a cohort in Taiwan: Reproductive factors and liver cancer. Journal of Gastroenterology and Hepatology 2011;26:334-9. [DOI: 10.1111/j.1440-1746.2010.06365.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
122 Liu SP, Li YS, Lee CM, Yen CH, Liao YJ, Huang SF, Chien CH, Chen YM. Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice. Int J Cancer 2011;128:511-23. [PMID: 20473876 DOI: 10.1002/ijc.25386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
123 Liang T, Mok K, Liu S, Huang S, Chou N, Tsai C, Chen I, Yeh M, Chen Y, Wang B. Hepatitis B Genotype C Correlated with Poor Surgical Outcomes for Hepatocellular Carcinoma. Journal of the American College of Surgeons 2010;211:580-6. [DOI: 10.1016/j.jamcollsurg.2010.06.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
124 Kao CC, Chen MK, Kuo WH, Chen TY, Su SC, Hsieh YH, Liu CL, Chou MC, Tsai HT, Yang SF. Influence of glutathione-S-transferase theta (GSTT1) and micro (GSTM1) gene polymorphisms on the susceptibility of hepatocellular carcinoma in Taiwan. J Surg Oncol 2010;102:301-7. [PMID: 20672314 DOI: 10.1002/jso.21643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2010;49:2381-90. [PMID: 20802007 DOI: 10.1093/rheumatology/keq277] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
126 Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2010;2:32ra35. [PMID: 20484730 DOI: 10.1126/scitranslmed.3001143] [Cited by in Crossref: 99] [Cited by in F6Publishing: 124] [Article Influence: 8.3] [Reference Citation Analysis]
127 Weng CJ, Tsai CM, Chen YC, Hsieh YH, Lin CW, Liu YF, Su SC, Chen MK, Yang SF. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol 2010;17:3394-401. [PMID: 20706793 DOI: 10.1245/s10434-010-1124-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
128 Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM. Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer. 2010;127:1011-1020. [PMID: 20017137 DOI: 10.1002/ijc.25118] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
129 He Y, Ni J, Chen S, Jiang Y, Jia S, Gao Y. The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese. DNA Cell Biol 2010;29:393-6. [PMID: 20406100 DOI: 10.1089/dna.2009.1015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
130 Liu J, Yang H, Lee M, Lu S, Jen C, Wang L, You S, Iloeje UH, Chen C. Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-Up Study. Gastroenterology 2010;139:474-82. [DOI: 10.1053/j.gastro.2010.04.048] [Cited by in Crossref: 176] [Cited by in F6Publishing: 159] [Article Influence: 14.7] [Reference Citation Analysis]
131 Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, Ma F, Huang W, Yu L, Yue W, Wang Z, Li P, Zhang Y, Liang R, Wei Z, Cui Y, Xie W, Cai M, Yu X, Yuan Y, Xia X, Zhang X, Yang H, Qiu W, Yang J, Gong F, Chen M, Shen H, Lin D, Zeng Y, He F, Zhou G. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010;42:755-8. [DOI: 10.1038/ng.638] [Cited by in Crossref: 243] [Cited by in F6Publishing: 240] [Article Influence: 20.3] [Reference Citation Analysis]
132 Tangkijvanich P, Sa-Nguanmoo P, Mahachai V, Theamboonlers A, Poovorawan Y. A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma. Hepatol Int. 2010;4:577-584. [PMID: 21063480 DOI: 10.1007/s12072-010-9197-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
133 Shivapurkar N, Gazdar AF. DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med. 2010;10:123-132. [PMID: 20196733 DOI: 10.2174/156652410790963303] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 6.0] [Reference Citation Analysis]
134 Gao SS, Chen XY, Zhu RZ, Choi B, Kim B. Sulforaphane induces glutathione S-transferase isozymes which detoxify aflatoxin B1-8,9-epoxide in AML 12 cells. BioFactors 2010;36:289-96. [DOI: 10.1002/biof.98] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
135 Lin HC, Lin CC. Surgeon volume is predictive of 5-year survival in patients with hepatocellular carcinoma after resection: a population-based study . J Gastrointest Surg 2009;13:2284-91. [PMID: 19730957 DOI: 10.1007/s11605-009-0990-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
136 Bekondi C, Mobima T, Ouavènè J, Koffi B, Konamna X, Béré A, Le Faou A. Étiopathologie du carcinome hépatocellulaire à Bangui, République centrafricaine : caractéristiques cliniques, biologiques et aspects virologiques des patients. Pathologie Biologie 2010;58:152-5. [DOI: 10.1016/j.patbio.2009.07.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
137 Zhang YJ. Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma. World J Hepatol 2010; 2(3): 94-102 [PMID: 21160980 DOI: 10.4254/wjh.v2.i3.94] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
138 Golden R, Doull J, Waddell W, Mandel J. Potential Human Cancer Risks from Exposure to PCBs: A Tale of Two Evaluations. Critical Reviews in Toxicology 2010;33:543-80. [DOI: 10.1080/10408440390242414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
139 Chen YL, Tseng HS, Kuo WH, Yang SF, Chen DR, Tsai HT. Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma. BMC Med Genet. 2010;11:46. [PMID: 20331903 DOI: 10.1186/1471-2350-11-46] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
140 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 725] [Cited by in F6Publishing: 718] [Article Influence: 60.4] [Reference Citation Analysis]
141 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Chen C, Chang M. HEPATITIS B AND PREGNANCY, THE SCIENTIFIC BASIS FOR PERINATAL PREVENTION. Fet Matern Med Rev 2010;21:89-113. [DOI: 10.1017/s0965539510000021] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
143 Liao YJ, Chen KH, Huang SF, Chen TL, Wang CK, Chien CH, Tsai TF, Liu SP, Chen YM. Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver. Proteomics Clin Appl 2010;4:394-406. [PMID: 21137059 DOI: 10.1002/prca.200900074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
144 Lin C, Kuo C, Lu C, Wu M, Huang RS. Elevated Serum Vitamin B 12 Levels in Association With Tumor Markers as the Prognostic Factors Predictive for Poor Survival in Patients With Hepatocellular Carcinoma. Nutrition and Cancer 2010;62:190-7. [DOI: 10.1080/01635580903305334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
145 Chen S, He Y, Ding J, Jiang Y, Jia S, Xia W, Zhao J, Lu M, Gu Z, Gao Y. An insertion/deletion polymorphism in the 3′ untranslated region of β-transducin repeat-containing protein (βTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochemical and Biophysical Research Communications 2010;391:552-6. [DOI: 10.1016/j.bbrc.2009.11.096] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
146 Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol. 2010;17:923-932. [PMID: 19898900 DOI: 10.1245/s10434-009-0790-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
147 Abel S, De Kock M, van Schalkwyk D, Swanevelder S, Kew M, Gelderblom W. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009;81:391-9. [DOI: 10.1016/j.plefa.2009.08.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
148 Hung H, Chen TH. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Vaccine 2009;27:6770-6. [DOI: 10.1016/j.vaccine.2009.08.082] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
149 Dong X, Zhou G, Zhai Y, Zhang H, Yang H, Zhi L, Zhang X, Chu J, He F. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers. Cancer Epidemiol. 2009;33:265-270. [PMID: 19766077 DOI: 10.1016/j.canep.2009.08.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
150 Bastani R, Glenn BA, Taylor VM, Chen MS, Nguyen TT, Stewart SL, Maxwell AE. Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Prev Med. 2010;50:63-67. [PMID: 19716379 DOI: 10.1016/j.ypmed.2009.08.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 5.6] [Reference Citation Analysis]
151 Kilickap S, Kars A, Hamaloglu E, Simsek H. A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection. Med Oncol 2009;26:501-5. [PMID: 19688614 DOI: 10.1007/s12032-008-9083-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
152 Chen C, Changchien C, Lee C, Tung W, Hung C, Hu T, Wang J, Wang J, Lu S. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer 2009;125:621-9. [DOI: 10.1002/ijc.24416] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
153 Kim YJ, Lee HS. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection]. Korean J Hepatol. 2009;15:7-14. [PMID: 19346781 DOI: 10.3350/kjhep.2009.15.1.7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
154 Bornkamm GW. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin Cancer Biol 2009;19:351-65. [PMID: 19619654 DOI: 10.1016/j.semcancer.2009.07.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
155 Fwu C, Chien Y, Kirk GD, Nelson KE, You S, Kuo H, Feinleib M, Chen C. Hepatitis B Virus Infection and Hepatocellular Carcinoma Among Parous Taiwanese Women: Nationwide Cohort Study. JNCI: Journal of the National Cancer Institute 2009;101:1019-27. [DOI: 10.1093/jnci/djp146] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
156 Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, Ma HJ, Chou MC, Tsai HT, Yang SF. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 2009;47:412-8. [PMID: 19327121 DOI: 10.1515/CCLM.2009.092] [Cited by in Crossref: 35] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
157 Zhang Y, Shen J, Lee YP, Santella RM. Telomere Length in Hepatocellular Carcinoma and Paired Adjacent Non-Tumor Tissues by Quantitative PCR. Cancer Investigation 2009;25:668-77. [DOI: 10.1080/07357900701561024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
158 Chen CJ, Yang HI, Iloeje UH; REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009;49:S72-84. [PMID: 19399801 DOI: 10.1002/hep.22884] [Cited by in Crossref: 235] [Cited by in F6Publishing: 222] [Article Influence: 18.1] [Reference Citation Analysis]
159 Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat. 2009;16:453-463. [PMID: 19302335 DOI: 10.1111/j.1365-2893.2009.01117.x] [Cited by in Crossref: 185] [Cited by in F6Publishing: 198] [Article Influence: 14.2] [Reference Citation Analysis]
160 Liao YJ, Liu SP, Lee CM, Yen CH, Chuang PC, Chen CY, Tsai TF, Huang SF, Lee YH, Chen YM. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. Int J Cancer. 2009;124:816-826. [PMID: 19035462 DOI: 10.1002/ijc.23979] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
161 Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009;2:2. [PMID: 19133145 DOI: 10.1186/1755-8794-2-2] [Cited by in Crossref: 317] [Cited by in F6Publishing: 302] [Article Influence: 24.4] [Reference Citation Analysis]
162 Wong RJ, Corley DA. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci. 2009;54:2031-2039. [PMID: 19117131 DOI: 10.1007/s10620-008-0661-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
163 Li R, Shugart YY, Zhou W, An Y, Yang Y, Zhou Y, Zhang B, Lu D, Wang H, Qian J, Jin L. Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population. Eur J Cancer 2009;45:1239-47. [PMID: 19110417 DOI: 10.1016/j.ejca.2008.11.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
164 Leenders MW, Nijkamp MW, Rinkes IHB. Mouse models in liver cancer research: A review of current literature. World J Gastroenterol 2008; 14(45): 6915-6923 [PMID: 19058325 DOI: 10.3748/wjg.14.6915] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
165 Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, Sivridis E, Papoutselis K. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(−) hepatitis B infection: Association with liver disease progression. A prospective cohort study. Journal of Hepatology 2008;49:884-91. [DOI: 10.1016/j.jhep.2008.06.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
166 Cao B, Chen XP, Zhu P, Ding L, Guan J, Shi ZL. Inhibitory effect of interferon-α-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice. World J Gastroenterol 2008; 14(44): 6802-6807 [PMID: 19058305 DOI: 10.3748/wjg.14.6802] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
167 Lee CY, Hsu YC, Wang JY, Chen CC, Chiu JH. Chemopreventive effect of selenium and Chinese medicinal herbs on N-nitrosobis(2-oxopropyl)amine-induced hepatocellular carcinoma in Syrian hamsters. Liver Int 2008;28:841-55. [PMID: 18346132 DOI: 10.1111/j.1478-3231.2008.01698.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
168 Yusof YA, Ahmad N, Das S, Sulaiman S, Murad NA. Chemopreventive efficacy of ginger (Zingiber officinale) in ethionine induced rat hepatocarcinogenesis. Afr J Tradit Complement Altern Med 2008;6:87-93. [PMID: 20162046 DOI: 10.4314/ajtcam.v6i1.57078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
169 Kanda M, Nomoto S, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol. 2008;98:190-196. [PMID: 18537151 DOI: 10.1002/jso.21095] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
170 Iser DM, Sasadeusz JJ. Current treatment of HIV/hepatitis B virus coinfection. J Gastroenterol Hepatol 2008;23:699-706. [PMID: 18410604 DOI: 10.1111/j.1440-1746.2008.05382.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
171 Chang C, Huang Z, Yu H, Chang L, Li S, Chen Y, Lee K, Chuu J. The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells. Journal of Ethnopharmacology 2008;118:387-95. [DOI: 10.1016/j.jep.2008.05.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 81] [Article Influence: 2.5] [Reference Citation Analysis]
172 Siegel AB, McBride RB, El-Serag HB, Hershman D, Brown RS Jr, Zablotska L, Neugut AI. The risk of hepatocellular carcinoma in patients with previous malignancy. Cancer Invest 2008;26:511-5. [PMID: 18568774 DOI: 10.1080/07357900701788007] [Reference Citation Analysis]
173 Wong R, Corley DA. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med 2008;121:525-31. [PMID: 18501235 DOI: 10.1016/j.amjmed.2008.03.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
174 Veenstra DL, Sullivan SD, Lai MY, Lee CM, Tsai CM, Patel KK. HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan. Value Health 2008;11:131-8. [PMID: 18380625 DOI: 10.1111/j.1524-4733.2007.00221.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
175 Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol 2008;103:914-21. [PMID: 18177453 DOI: 10.1111/j.1572-0241.2007.01712.x] [Cited by in Crossref: 289] [Cited by in F6Publishing: 289] [Article Influence: 20.6] [Reference Citation Analysis]
176 Sullivan SD, Veenstra DL, Chen PJ, Chang TT, Chuang WL, Tsai C, Patel K. Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. J Gastroenterol Hepatol 2007;22:1494-9. [PMID: 17716353 DOI: 10.1111/j.1440-1746.2006.04539.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
177 Sarin SK, Kumar M. Should chronic HBV infected patients with normal ALT treated: debate. Hepatol Int 2008;2:179-84. [PMID: 19669302 DOI: 10.1007/s12072-008-9065-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
178 Kim CJ, Song JH, Cho YG, Cao Z, Lee YS, Nam SW, Lee JY, Park WS. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma. Histopathology 2008;52:552-9. [PMID: 18312352 DOI: 10.1111/j.1365-2559.2008.02980.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
179 Kong S, Ki C, Yoo BC, Kim J. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers. Cancer Science 2008;99:340-4. [DOI: 10.1111/j.1349-7006.2007.00693.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
180 Ferrand J, Cénée S, Laurent-puig P, Loriot M, Trinchet JC, Degos F, Bronovicky J, Pelletier G, Stücker I. Hepatocellular Carcinoma and Occupation in Men: A Case-Control Study. Journal of Occupational & Environmental Medicine 2008;50:212-20. [DOI: 10.1097/jom.0b013e31815d88e2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
181 Gazzana G, Borlak J. Mapping of the serum proteome of hepatocellular carcinoma induced by targeted overexpression of epidermal growth factor to liver cells of transgenic mice. J Proteome Res. 2008;7:928-937. [PMID: 18198842 DOI: 10.1021/pr070462c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
182 Mishra D, Flora SJS. Quercetin Administration During Chelation Therapy Protects Arsenic-Induced Oxidative Stress in Mice. Biol Trace Elem Res 2008;122:137-47. [DOI: 10.1007/s12011-007-8064-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
183 Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106:148-155. [PMID: 17339159 DOI: 10.1016/s0929-6646(09)60231-x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 74] [Article Influence: 12.1] [Reference Citation Analysis]
184 Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, Liang JD, Chiou LL, Huang GT, Lee HS. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int J Cancer. 2007;121:1257-1264. [PMID: 17534893 DOI: 10.1002/ijc.22849] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
185 Chen C, Iloeje UH, Yang H. Long-Term Outcomes in Hepatitis B: The REVEAL-HBV Study. Clinics in Liver Disease 2007;11:797-816. [DOI: 10.1016/j.cld.2007.08.005] [Cited by in Crossref: 131] [Cited by in F6Publishing: 119] [Article Influence: 8.7] [Reference Citation Analysis]
186 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
187 Hara M, Tanaka K, Sakamoto T, Higaki Y, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S. Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci 2008;99:93-7. [PMID: 17956590 DOI: 10.1111/j.1349-7006.2007.00645.x] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
188 Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, Cotler SJ, Fontana RJ, McCashland TM, Han SH, Gordon FD, Schilsky ML, Kowdley KV. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int. 2007;27:1394-1401. [PMID: 17927713 DOI: 10.1111/j.1478-3231.2007.01596.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
189 Huang HH, Chang PH, Fang TJ. Sinonasal metastatic hepatocellular carcinoma. Am J Otolaryngol 2007;28:238-41. [PMID: 17606038 DOI: 10.1016/j.amjoto.2006.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
190 Yan ZC, Chen D, Wu XZ, Xie GR, Ba Y, Yan Z. Effects of aqueous extracts of Aconitum carmichaeli, Rhizoma bolbostemmatis, Phytolacca acinosa, Panax notoginseng and Gekko swinhonis Gūenther on Bel-7402 cells. World J Gastroenterol 2007; 13(19): 2743-2746 [PMID: 17569146 DOI: 10.3748/wjg.v13.i19.2743] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
191 Yeh SH, Chiu CM, Chen CL, Lu SF, Hsu HC, Chen DS, Chen PJ. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int J Cancer. 2007;120:1610-1617. [PMID: 17230529 DOI: 10.1002/ijc.22479] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
192 Budhu A, Chen Y, Kim JW, Forgues M, Valerie K, Harris CC, Wang XW. Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis 2007;28:1552-60. [PMID: 17404395 DOI: 10.1093/carcin/bgm075] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
193 Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 2007;236:7-15. [PMID: 17451858 DOI: 10.1016/j.tox.2007.03.021] [Cited by in Crossref: 112] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
194 Baek JY, Hur W, Wang JS, Bae SH, Yoon SK. Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J Gastroenterol 2007; 13(8): 1175-1181 [PMID: 17451196 DOI: 10.3748/wjg.v13.i8.1175] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
195 Liu J, Xie Y, Cooper R, Ducharme DM, Tennant R, Diwan BA, Waalkes MP. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol Appl Pharmacol 2007;220:284-91. [PMID: 17350061 DOI: 10.1016/j.taap.2007.01.018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
196 Carozza SE, Howe HL. Patterns of cancer incidence among US Hispanics/Latinos, 1995-2000. Cancer Causes Control 2006;17:1067-75. [PMID: 16933057 DOI: 10.1007/s10552-006-0045-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
197 Chen C, Iloeje UH, Yang H. Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinoma. Current Hepatitis Reports 2007;6:9-16. [DOI: 10.1007/bf02942173] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
198 Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Yang WJ, Chen DS. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A. 2007;104:2571-2578. [PMID: 17259306 DOI: 10.1073/pnas.0609498104] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 6.3] [Reference Citation Analysis]
199 Chen CH, Su WW, Yang SS, Chang TT, Cheng KS, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan. J Gastroenterol Hepatol. 2006;21:1561-1566. [PMID: 16928217 DOI: 10.1111/j.1440-1746.2006.04425.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
200 Liaw Y, Sollano JD. Factors influencing liver disease progression in chronic hepatitis B. Liver International 2006;26:23-9. [DOI: 10.1111/j.1478-3231.2006.01372.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
201 Hersoug LG, Arnau J. A built-in co-carcinogenic effect due to viruses involved in latent or persistent infections. Med Hypotheses 2007;68:1001-8. [PMID: 17125934 DOI: 10.1016/j.mehy.2006.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
202 Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, Lin HH, Wu SS, Lee CM, Changchien CS. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer. 2006;119:1946-1952. [PMID: 16708389 DOI: 10.1002/ijc.22045] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 5.4] [Reference Citation Analysis]
203 Zhang YJ, Rossner P Jr, Chen Y, Agrawal M, Wang Q, Wang L, Ahsan H, Yu MW, Lee PH, Santella RM. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. Int J Cancer 2006;119:985-91. [PMID: 16570275 DOI: 10.1002/ijc.21699] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
204 Liu J, Xie Y, Ducharme DM, Shen J, Diwan BA, Merrick BA, Grissom SF, Tucker CJ, Paules RS, Tennant R, Waalkes MP. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ Health Perspect 2006;114:404-11. [PMID: 16507464 DOI: 10.1289/ehp.8534] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
205 Tanaka K, Tsuji I, Wakai K, Nagata C, Mizoue T, Inoue M, Tsugane S; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Jpn J Clin Oncol. 2006;36:445-456. [PMID: 16782973 DOI: 10.1093/jjco/hyl040] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
206 Han J, Ding L, Yuan B, Yang X, Wang X, Li J, Lu Q, Huang C, Ye Q. Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. Nucleic Acids Res. 2006;34:3095-3106. [PMID: 16757575 DOI: 10.1093/nar/gkl389] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
207 Yuan X, Xu C, Pan Z, Keum Y, Kim J, Shen G, Yu S, Oo KT, Ma J, Kong AT. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells: ACTIVATION OF Nrf2-ARE SIGNALING BY BHA AND MAPK. Mol Carcinog 2006;45:841-50. [DOI: 10.1002/mc.20234] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
208 Abdel-wahhab MA, Ahmed HH, Hagazi MM. Prevention of aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts. J Appl Toxicol 2006;26:229-38. [DOI: 10.1002/jat.1127] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
209 Hsu WC, Chan SC, Ting LL, Chung NN, Wang PM, Ying KS, Shin JS, Chao CJ, Lin GD. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma. Jpn J Clin Oncol. 2006;36:93-99. [PMID: 16517834 DOI: 10.1093/jjco/hyi242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
210 Keasler VV, Lerat H, Madden CR, Finegold MJ, Mcgarvey MJ, Mohammed EM, Forbes SJ, Lemon SM, Hadsell DL, Grona SJ, Hollinger FB, Slagle BL. Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology 2006;347:466-75. [DOI: 10.1016/j.virol.2005.11.050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
211 Shindo M, Hamada K, Muramatsu A, Morikawa T, Okuno T. Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B. J Gastroenterol 2006;41:151-7. [PMID: 16568374 DOI: 10.1007/s00535-005-1734-5] [Reference Citation Analysis]
212 Zhai Y, Zhou G, Deng G, Xie W, Dong X, Zhang X, Yu L, Yang H, Yuan X, Zhang H. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology. 2006;130:2001-2009. [PMID: 16762623 DOI: 10.1053/j.gastro.2006.02.030] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
213 Zervou EK, Gatselis NK, Xanthi E, Ziciadis K, Georgiadou SP, Dalekos GN. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol 2005;17:911-5. [PMID: 16093867 DOI: 10.1097/00042737-200509000-00005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
214 Wong IHN, Lo YMD, Johnson PJ. Epigenetic Tumor Markers in Plasma and Serum: Biology and Applications to Molecular Diagnosis and Disease Monitoring. Annals of the New York Academy of Sciences 2001;945:36-50. [DOI: 10.1111/j.1749-6632.2001.tb03862.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
215 Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Ray RM, Gao DL, Wernli KJ, Fitzgibbons ED, Vaughan TL, Checkoway H. Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study. Int J Epidemiol. 2006;35:361-369. [PMID: 16373377 DOI: 10.1093/ije/dyi282] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
216 El-Kafrawy SA, Abdel-Hamid M, El-Daly M, Nada O, Ismail A, Ezzat S, Abdel-Latif S, Abdel-Hamid A, Shields PG, Loffredo C. P53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health 2005;208:263-70. [PMID: 16078640 DOI: 10.1016/j.ijheh.2005.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
217 Liu J, Xie Y, Merrick BA, Shen J, Ducharme DM, Collins J, Diwan BA, Logsdon D, Waalkes MP. Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver. Toxicol Appl Pharmacol 2006;213:216-23. [PMID: 16368122 DOI: 10.1016/j.taap.2005.10.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
218 Ezzat S, Abdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, Mikhail NN, Abdel-Hamid A, Hifnawy T, Strickland GT. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health. 2005;208:329-339. [PMID: 16217918 DOI: 10.1016/j.ijheh.2005.04.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
219 Pascale RM, Simile MM, Calvisi DF, Frau M, Muroni MR, Seddaiu MA, Daino L, Muntoni MD, De Miglio MR, Thorgeirsson SS, Feo F. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Hepatology 2005;42:1310-9. [PMID: 16317707 DOI: 10.1002/hep.20962] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.0] [Reference Citation Analysis]
220 Jiang X, Orr BA, Kranz DM, Shapiro DJ. Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 2006;147:1419-26. [PMID: 16306080 DOI: 10.1210/en.2005-0996] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
221 Pang R, Tse E, Poon RT. Molecular pathways in hepatocellular carcinoma. Cancer Lett. 2006;240:157-169. [PMID: 16239065 DOI: 10.1016/j.canlet.2005.08.031] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
222 Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW. The molecular signature of metastases of human hepatocellular carcinoma. Oncology. 2005;69 Suppl 1:23-27. [PMID: 16210873 DOI: 10.1159/000086628] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
223 Tseng CS, Tang KS, Lo HW, Ker CG, Teng HC, Huang CS. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 2005;100:1758-63. [PMID: 16086712 DOI: 10.1111/j.1572-0241.2005.41857.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
224 Li H, Fu X, Chen Y, Hong Y, Tan Y, Cao H, Wu M, Wang H. Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma. Gastroenterology. 2005;128:2029-2041. [PMID: 15940635 DOI: 10.1053/j.gastro.2005.03.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
225 Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int. 2005;25:380-388. [PMID: 15780064 DOI: 10.1111/j.1478-3231.2005.1059.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.0] [Reference Citation Analysis]
226 Gatza ML, Chandhasin C, Ducu RI, Marriott SJ. Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation. Environ Mol Mutagen. 2005;45:304-325. [PMID: 15645440 DOI: 10.1002/em.20088] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
227 Lin C, Liao L, Wang C, Chen P, Lai M, Chen D, Kao J. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 2005;25:564-70. [DOI: 10.1111/j.1478-3231.2005.01041.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
228 Le Roux E, Gormally E, Hainaut P. Somatic mutations in human cancer: applications in molecular epidemiology. Revue d'Épidémiologie et de Santé Publique 2005;53:257-66. [DOI: 10.1016/s0398-7620(05)84603-6] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
229 Chen C. Time-dependent events in natural history of occult hepatitis B virus infection: the importance of population-based long-term follow-up study with repeated measurements. Journal of Hepatology 2005;42:438-40. [DOI: 10.1016/j.jhep.2005.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
230 Wunderlich F, Dkhil MA, Mehnert LI, Braun JV, El-khadragy M, Borsch E, Hermsen D, Benten WPM, Pfeffer K, Mossmann H, Krücken J. Testosterone responsiveness of spleen and liver in female lymphotoxin β receptor-deficient mice resistant to blood-stage malaria. Microbes and Infection 2005;7:399-409. [DOI: 10.1016/j.micinf.2004.11.016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
231 Huang L, Coughtrie MW, Hsu H. Down-regulation of dehydroepiandrosterone sulfotransferase gene in human hepatocellular carcinoma. Molecular and Cellular Endocrinology 2005;231:87-94. [DOI: 10.1016/j.mce.2004.10.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
232 Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci 2005;2:50-7. [PMID: 15968340 DOI: 10.7150/ijms.2.50] [Cited by in Crossref: 164] [Cited by in F6Publishing: 170] [Article Influence: 9.6] [Reference Citation Analysis]
233 Kim YJ, Lee H. Single Nucleotide Polymorphisms Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection. Intervirology 2005;48:10-5. [DOI: 10.1159/000082089] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
234 Tanaka O, Kanematsu M, Kondo H, Goshima S, Nishibori H, Kato H, Kiryu T, Yokoyama R, Hoshi H, Moriyama N. Solitary mediastinal lymph node metastasis of hepatocellular carcinoma: MR imaging findings. Magnetic Resonance Imaging 2005;23:111-4. [DOI: 10.1016/j.mri.2004.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
235 Chen CH, Chen YY, Chen GH, Yang SS, Tang HS, Lin HH, Lin DY, Lo SK, Du JM, Chang TT. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma. J Hepatol. 2004;40:653-659. [PMID: 15030982 DOI: 10.1016/j.jhep.2003.12.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
236 Xie Y, Trouba KJ, Liu J, Waalkes MP, Germolec DR. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ Health Perspect 2004;112:1255-63. [PMID: 15345372 DOI: 10.1289/txg.7152] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 0.3] [Reference Citation Analysis]
237 Xie Y, Trouba KJ, Liu J, Waalkes MP, Germolec DR. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ Health Perspect. 2004;112:1255-1263. [PMID: 15345372 DOI: 10.1289/ehp.7152] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
238 Mourad YA, Khalifeh M, Taher A, Tawil A, Shamseddine A. Hepatocellular carcinoma with isolated left adrenal metastasis following liver transplantation. Ann Saudi Med 2004;24:65-7. [PMID: 15310025 DOI: 10.5144/0256-4947.2004.65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
239 Chiu HF, Ho SC, Wang LY, Wu TN, Yang CY. Does arsenic exposure increase the risk for liver cancer? J Toxicol Environ Health A. 2004;67:1491-1500. [PMID: 15371225 DOI: 10.1080/15287390490486806] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
240 Yeh S, Lin M, Lu S, Wu D, Tsai S, Tsai C, Lai M, Hsu H, Chen D, Chen P. Allelic loss of chromosome 4q21 ≍ 23 associates with hepatitis B Virus—related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology 2004;40:847-54. [DOI: 10.1002/hep.1840400414] [Reference Citation Analysis]
241 Yeh SH, Lin MW, Lu SF, Wu DC, Tsai SF, Tsai CY, Lai MY, Hsu HC, Chen DS, Chen PJ. Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology 2004;40:847-54. [PMID: 15382172 DOI: 10.1002/hep.20409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
242 Yin PH, Lee HC, Chau GY, Liu TY, Liu HC, Lui WY, Chi CW. Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett 2004;212:195-201. [PMID: 15341023 DOI: 10.1016/j.canlet.2004.04.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
243 Yin PH, Lee HC, Chau GY, Wu YT, Li SH, Lui WY, Wei YH, Liu TY, Chi CW. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer. 2004;90:2390-2396. [PMID: 15150555 DOI: 10.1038/sj.bjc.6601838] [Cited by in Crossref: 142] [Cited by in F6Publishing: 133] [Article Influence: 7.9] [Reference Citation Analysis]
244 Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore). 2004;83:176-187. [PMID: 15118544 DOI: 10.1097/01.md.0000126971.80227.a4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
245 Fu X, Tan L, Liu S, Li H, Chen L, Qin J, Wu M, Wang H. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. J Cancer Res Clin Oncol 2004;130:514-20. [PMID: 15221469 DOI: 10.1007/s00432-004-0562-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
246 Waalkes MP, Liu J, Ward JM, Diwan BA. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 2004;198:31-8. [PMID: 15138027 DOI: 10.1016/j.tox.2004.01.017] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
247 Feitelson MA, Pan J, Lian Z. Early molecular and genetic determinants of primary liver malignancy. Surg Clin North Am. 2004;84:339-354. [PMID: 15062649 DOI: 10.1016/s0039-6109(03)00226-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
248 Dohmen K, Shigematsu H, Irie K, Ishibashi H. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology. 2003;50:2022-2027. [PMID: 14696457 DOI: 10.1016/j.ejca.2006.06.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
249 Man XB, Tang L, Qiu XH, Yang LQ, Cao HF, Wu MC, Wang HY. Expression of cytochrome P4502E1 gene in hepatocellular carcinoma. World J Gastroenterol 2004; 10(11): 1565-1568 [PMID: 15162526 DOI: 10.3748/wjg.v10.i11.1565] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
250 Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(11): 1547-1550 [PMID: 15162522 DOI: 10.3748/wjg.v10.i11.1547] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
251 Lu S, Chow N, Wu W, Chang T, Huang W, Chen S, Lin C, Carr BI. Characteristics of Hepatocellular Carcinoma in a High Arsenicism Area in Taiwan: A Case???Control Study: . Journal of Occupational and Environmental Medicine 2004;46:437-41. [DOI: 10.1097/01.jom.0000126023.32772.23] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
252 Ouyang GL, Cai QF, Liu M, Chen RC, Huang Z, Jiang RS, Chen F, Hong SG, Bao SD. Growth arrest and apoptosis of human hepatocellular carcinoma cells induced by hexamethylene bisacetamide. World J Gastroenterol 2004; 10(7): 954-958 [PMID: 15052673 DOI: 10.3748/wjg.v10.i7.954] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
253 Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, Cheng ML, Diwan BA. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst 2004;96:466-74. [PMID: 15026472 DOI: 10.1093/jnci/djh070] [Cited by in Crossref: 134] [Cited by in F6Publishing: 116] [Article Influence: 7.4] [Reference Citation Analysis]
254 Hedri H, Mhibik S, Abderrahim E, Goucha R, Ben Taarit C, Kheder A, Ben Moussa F, Zermani R, Ben Jilani S, Ben Maïz H. Métastase sternale révélatrice d'un hépatocarcinome. La Revue de Médecine Interne 2004;25:238-41. [DOI: 10.1016/j.revmed.2003.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
255 Song H, Xia SL, Liao C, Li YL, Wang YF, Li TP, Zhao MJ. Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma. World J Gastroenterol 2004; 10(4): 509-513 [PMID: 14966907 DOI: 10.3748/wjg.v10.i4.509] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
256 Roebuck B. Hyperplasia, partial hepatectomy, and the carcinogenicity of aflatoxin B1. J Cell Biochem 2004;91:243-9. [DOI: 10.1002/jcb.10758] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
257 Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology 2003;38:1393-400. [PMID: 14647050 DOI: 10.1016/j.hep.2003.09.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 55] [Article Influence: 1.2] [Reference Citation Analysis]
258 Thompson MJ, Taylor VM, Yasui Y, Hislop TG, Jackson JC, Kuniyuki A, Teh C. Hepatitis B knowledge and practices among Chinese Canadian women in Vancouver, British Columbia. Can J Public Health 2003;94:281-6. [PMID: 12873087 [PMID: 12873087 DOI: 10.1007/bf03403606] [Cited by in Crossref: 37] [Article Influence: 1.9] [Reference Citation Analysis]
259 Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY, Lee SD. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol 2003;98:1417-22. [PMID: 12818290 DOI: 10.1111/j.1572-0241.2003.07452.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
260 Lee LJ, Chung CW, Ma YC, Wang GS, Chen PC, Hwang YH, Wang JD. Increased mortality odds ratio of male liver cancer in a community contaminated by chlorinated hydrocarbons in groundwater. Occup Environ Med 2003;60:364-9. [PMID: 12709523 DOI: 10.1136/oem.60.5.364] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
261 Staib F, Hussain SP, Hofseth LJ, Wang XW, Harris CC. TP53 and liver carcinogenesis. Hum Mutat. 2003;21:201-216. [PMID: 12619106 DOI: 10.1002/humu.10176] [Cited by in Crossref: 157] [Cited by in F6Publishing: 152] [Article Influence: 8.3] [Reference Citation Analysis]
262 Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, Hofseth LJ, Brechot C, Harris CC. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology. 2002;181-182:43-47. [PMID: 12505283 DOI: 10.1016/s0300-483x(02)00253-6] [Cited by in Crossref: 119] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
263 Matsuo K, Satoh S, Okabe H, Nomura A, Maeda T, Yamaoka Y, Ikai I. SIAH1 inactivation correlates with tumor progression in hepatocellular carcinomas. Genes Chromosom Cancer 2003;36:283-91. [DOI: 10.1002/gcc.10170] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
264 Farker K, Schotte U, Scheele J, Hoffmann A. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC) – an investigation in a department of surgical medicine. Experimental and Toxicologic Pathology 2003;54:387-91. [DOI: 10.1078/0940-2993-00275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
265 Sun CA, Wu DM, Wang LY, Chen CJ, You SL, Santella RM. Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan. Br J Cancer 2002;87:966-70. [PMID: 12434285 DOI: 10.1038/sj.bjc.6600584] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
266 Tai DI, Chen CH, Chang TT, Chen SC, Liao LY, Kuo CH, Chen YY, Chen GH, Yang SS, Tang HS. Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection. J Gastroenterol Hepatol. 2002;17:682-689. [PMID: 12100614 DOI: 10.1046/j.1440-1746.2002.02747.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
267 Madden CR, Finegold MJ, Slagle BL. Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol 2002;76:11770-4. [PMID: 12388740 DOI: 10.1128/jvi.76.22.11770-11774.2002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
268 Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer. 2002;2:29. [PMID: 12433278 DOI: 10.1186/1471-2407-2-29] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 5.7] [Reference Citation Analysis]
269 Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol Carcinog 2002;35:85-92. [PMID: 12325038 DOI: 10.1002/mc.10076] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
270 Chen CJ, Chen DS. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 2002;36:1046-9. [PMID: 12395312 DOI: 10.1053/jhep.2002.37084] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 4.5] [Reference Citation Analysis]
271 Yang T, Wang C, Hsieh R, Chen J, Fung M. Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I–II trial. Annals of Oncology 2002;13:1771-8. [DOI: 10.1093/annonc/mdf303] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
272 Tai DI, Lo SK, Kuo CH, Du JM, Chen CJ, Hung CS, Chu CM. Replication of hepatitis B in HBsAg-positive siblings. J Viral Hepat. 2002;9:272-279. [PMID: 12081604 DOI: 10.1046/j.1365-2893.2002.00353.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
273 Chen SY, Wang LY, Lunn RM, Tsai WY, Lee PH, Lee CS, Ahsan H, Zhang YJ, Chen CJ, Santella RM. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer. 2002;99:14-21. [PMID: 11948486 DOI: 10.1002/ijc.10291] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 3.9] [Reference Citation Analysis]
274 Chen CJ, You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32 Suppl:S66-S81. [PMID: 11959880 DOI: 10.1093/jjco/hye138] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 6.2] [Reference Citation Analysis]
275 Pärssinen M, Seppälä T. Steroid use and long-term health risks in former athletes. Sports Med 2002;32:83-94. [PMID: 11817994 DOI: 10.2165/00007256-200232020-00001] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 4.1] [Reference Citation Analysis]
276 Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS, Duffy SW. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer. 2002;98:257-261. [PMID: 11857416 DOI: 10.1002/ijc.10122] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 5.3] [Reference Citation Analysis]
277 Zhang Y, Chen S, Chen C, Santella RM. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma. Mol Carcinog 2002;33:125-9. [DOI: 10.1002/mc.10028] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
278 Porru S, Placidi D, Carta A, Gelatti U, Ribero ML, Tagger A, Boffetta P, Donato F. Primary liver cancer and occupation in men: a case-control study in a high-incidence area in Northern Italy. Int J Cancer. 2001;94:878-883. [PMID: 11745492 DOI: 10.1002/ijc.1538] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
279 Zhou ZQ, Manguino D, Kewitt K, Intano GW, McMahan CA, Herbert DC, Hanes M, Reddick R, Ikeno Y, Walter CA. Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase. Proc Natl Acad Sci U S A 2001;98:12566-71. [PMID: 11606727 DOI: 10.1073/pnas.221232998] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
280 Aguayo A, Patt YZ. Liver cancer. Clin Liver Dis. 2001;5:479-507. [PMID: 11385973 DOI: 10.1016/s1089-3261(05)70175-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
281 Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology. 2001;121:699-709. [PMID: 11522754 DOI: 10.1053/gast.2001.27211] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 3.3] [Reference Citation Analysis]
282 Nakatani T, Roy G, Fujimoto N, Asahara T, Ito A. Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin. Jpn J Cancer Res. 2001;92:249-256. [PMID: 11267934 DOI: 10.1111/j.1349-7006.2001.tb01089.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 4.1] [Reference Citation Analysis]
283 Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P, Thomas HC. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816-20. [PMID: 11358902 DOI: 10.1136/gut.48.6.816] [Cited by in Crossref: 268] [Cited by in F6Publishing: 255] [Article Influence: 12.8] [Reference Citation Analysis]
284 Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, Das BC. Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations. J Gastroenterol Hepatol 2001;16:666-73. [DOI: 10.1046/j.1440-1746.2001.02476.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
285 Madden CR, Finegold MJ, Slagle BL. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol. 2001;75:3851-3858. [PMID: 11264374 DOI: 10.1128/jvi.75.8.3851-3858.2001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
286 Liu LH, Xiao WH, Liu WW. Effect of 5-2Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2. World J Gastroenterol 2001; 7(1): 131-135 [PMID: 11819749 DOI: 10.3748/wjg.v7.i1.131] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
287 Farinati F, Gianni S. Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?: . European Journal of Cancer Prevention 2001;10:111-5. [DOI: 10.1097/00008469-200102000-00017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
288 Aguayo A, Patt YZ. Nonsurgical Treatment of Hepatocellular Carcinoma. Clinics in Liver Disease 2001;5:175-89. [DOI: 10.1016/s1089-3261(05)70160-4] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
289 Tackels-horne D, Goodman MD, Williams AJ, Wilson DJ, Eskandari T, Vogt LM, Boland JF, Scherf U, Vockley JG. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 2001;92:395-405. [DOI: 10.1002/1097-0142(20010715)92:2<395::aid-cncr1335>3.0.co;2-u] [Cited by in Crossref: 57] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
290 Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15 Suppl:E3-E6. [PMID: 10921373 DOI: 10.1046/j.1440-1746.2000.02124.x] [Cited by in Crossref: 161] [Cited by in F6Publishing: 149] [Article Influence: 7.3] [Reference Citation Analysis]
291 Chen CY, Chau GY, Yen SH, Hsieh YH, Chao Y, Chi KH, Li CP, Chang FY, Lee SD. Life-threatening haemorrhage from a sternal metastatic hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15:684-687. [PMID: 10921426 DOI: 10.1046/j.1440-1746.2000.02194.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
292 Wong IHN, Lo YMD, Lai PBS, Johnson PJ. Relationship of p16 Methylation Status and Serum α-Fetoprotein Concentration in Hepatocellular Carcinoma Patients. Clinical Chemistry 2000;46:1420-2. [DOI: 10.1093/clinchem/46.9.1420] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
293 Gushulak BD, Macpherson DW. Population Mobility and Infectious Diseases: The Diminishing Impact of Classical Infectious Diseases and New Approaches for the 21st Century. Clinical Infectious Diseases 2000;31:776-80. [DOI: 10.1086/313998] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
294 Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology. 2000;119:172-180. [PMID: 10889166 DOI: 10.1053/gast.2000.8559] [Cited by in Crossref: 521] [Cited by in F6Publishing: 473] [Article Influence: 23.7] [Reference Citation Analysis]
295 Wong NA, Rae F, Simpson KJ, Murray GD, Harrison DJ. Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. Mol Pathol. 2000;53:88-93. [PMID: 10889908 DOI: 10.1136/mp.53.2.88] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
296 Cheng JC, Chuang VP, Cheng SH, Huang AT, Lin YM, Cheng TI, Yang PS, You DL, Jian JJ, Tsai SY. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2000;47:435-442. [PMID: 10802371 DOI: 10.1016/s0360-3016(00)00462-4] [Cited by in Crossref: 130] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
297 Chu C. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000;15:E25-30. [DOI: 10.1046/j.1440-1746.2000.02097.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 108] [Article Influence: 5.3] [Reference Citation Analysis]
298 Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T, Katsura N, Nishitai R, Takeyama O, Fukumoto M, Yamaoka Y. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology 2000;31:1073-9. [PMID: 10796882 DOI: 10.1053/he.2000.6409] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 3.4] [Reference Citation Analysis]
299 Lin GY, Chen ZL, Lu CM, Li Y, Ping XJ, Huang R. Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol 2000; 6(2): 234-238 [PMID: 11819564 DOI: 10.3748/wjg.v6.i2.234] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
300 Hussain S, Harris CC. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutation Research/Reviews in Mutation Research 2000;462:311-22. [DOI: 10.1016/s1383-5742(00)00015-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
301 Gale CR, Braidwood EA, Winter PD, Martyn CN. Mortality from Parkinson's disease and other causes in men who were prisoners of war in the Far East. Lancet 1999;354:2116-8. [PMID: 10609817 DOI: 10.1016/S0140-6736(99)06264-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
302 Estrov Z, Manna SK, Harris D, Van Q, Estey EH, Kantarjian HM, Talpaz M, Aggarwal BB. Phenylarsine Oxide Blocks Interleukin-1β–Induced Activation of the Nuclear Transcription Factor NF-κB, Inhibits Proliferation, and Induces Apoptosis of Acute Myelogenous Leukemia Cells. Blood 1999;94:2844-53. [DOI: 10.1182/blood.v94.8.2844.420k43_2844_2853] [Cited by in Crossref: 64] [Article Influence: 2.8] [Reference Citation Analysis]
303 Jode MG, Lamb GM, Thomas HC, Taylor-robinson SD, Gedroyc WM. MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: technique and early progress. Journal of Hepatology 1999;31:347-53. [DOI: 10.1016/s0168-8278(99)80234-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
304 Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM. PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene. 1999;18:3181-3185. [PMID: 10340391 DOI: 10.1038/sj.onc.1202659] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 3.4] [Reference Citation Analysis]
305 Lin S, Sheen I, Chien R, Chu C, Liaw Y. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999;29:971-5. [DOI: 10.1002/hep.510290312] [Cited by in Crossref: 328] [Cited by in F6Publishing: 291] [Article Influence: 14.3] [Reference Citation Analysis]